Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

Founded in 2018, Defiance is at the forefront of ETF innovation. Defiance is a leading ETF issuer specializing in thematic, ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late. Shares of the ...

Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks ...

In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $34.71, marking a +0.7% move from the previous day.

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks ...

Analysts are closely monitoring how these developments will affect Hims & Hers' business model and revenue projections. The ongoing legal proceedings and competitive dynamics present uncertainties ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

The Urban Development Corporation of Trinidad and Tobago Limited (UDeCOTT) says it is refuting statements that it “opened” ...

At the end of the month, policies that expanded Medicare coverage for telehealth during the pandemic will expire, unless ...